Nasopharynx carcinoma

Clinical trials for Nasopharynx carcinoma explained in plain language.

Never miss a new study

Get alerted when new Nasopharynx carcinoma trials appear

Sign up with your email to follow new studies for Nasopharynx carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1

Immunotherapy duo aims to shrink nasopharyngeal tumors before standard treatment

Disease control Not yet recruiting

This trial tests whether adding the immunotherapy drugs cemiplimab (with or without fianlimab) to standard chemotherapy before chemoradiation can improve outcomes for people with advanced nasopharyngeal cancer. About 60 adults with non-metastatic, EBV-positive nasopharyngeal carc…

Matched conditions: NASOPHARYNX CARCINOMA

Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

Nasopharynx carcinoma

Get alerted when new Nasopharynx carcinoma trials appear

Immunotherapy duo aims to shrink nasopharyngeal tumors before standard treatment